Inicio » 2021 » Volume 7 - Number 2 » Non-invasive Biomarkers of Idiopathic Pulmonary Fibrosis and Lung Cancer
Martina Armati 1, Olivia Michalczyszyn 1, Katarzyna Zaczyk 1, Siena IPF team
1 Respiratory Medicine, Department of Medical Sciences, Surgery, and Neurosciences, Siena University, Siena, Italy
*Correspondence: Katarzyna Zaczyk, Email not available
Introduction: The aim of this article is to collect and summarize the evidence related to the role of non-invasive biomarkers in lung cancer and idiopathic pulmonary fibrosis (IPF), to better understand the point in common of these two conditions and the possible uses, and to better understand and define these diseases individually and together. Methods: The methodology for this study consisted of a systematic review searching on PubMed covering the period between 2000 and 2020. From this research, only 13 articles were considered as most relevant regarding this theme. Conclusion: This review provides a current state of knowledge regarding the use of non-invasive biomarkers in lung cancer and IPF to address clinical practice and research proposals to better understand the correlation between IPF and lung cancer and to give other possible information about the severity and the prognosis in IPF patients.